+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell-Free DNA Testing Market - Global Forecast 2025-2030- Product Image
Cell-Free DNA Testing Market - Global Forecast 2025-2030- Product Image
Sale

Cell-Free DNA Testing Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055596
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cell-free DNA (cfDNA) testing is transforming patient care, offering noninvasive and accurate methods for early disease detection, monitoring, and prognosis across diverse clinical settings. As precision medicine advances, cfDNA testing has rapidly become essential for organizations seeking superior diagnostic solutions and operational efficiencies.

Market Snapshot: Cell-Free DNA Testing Market Size & Growth

The cell-free DNA testing market grew from USD 6.70 billion in 2024 to USD 7.19 billion in 2025, and it is anticipated to maintain robust expansion at a CAGR of 7.52%, reaching USD 10.36 billion by 2030. Growth is driven by expanding noninvasive applications in oncology, prenatal care, infectious diseases, and transplantation. Increasing clinical demand, regulatory advances, and strategic positioning by industry leaders are reshaping the competitive landscape.

Scope & Segmentation

This market research dissects the cell-free DNA testing sector by offerings, technologies, end-users, geographies, and leading companies to provide actionable insights for senior stakeholders.

  • Offerings: Infectious diseases testing, oncology and cancer management (including early detection, screening, and minimal residual disease assessment), prenatal screening (noninvasive prenatal and preimplantation genetic testing), transplantation testing.
  • Technology Platforms: Mass spectrometry for molecular analysis, microfluidics for streamlining samples, nucleic acid technologies, polymerase chain reaction (PCR), single-molecule methylation for epigenetic biomarker discovery.
  • End-User Segments: Diagnostic laboratories and testing centers, hospitals, and clinics—each with unique workflow integration needs and service models.
  • Geographic Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, and additional countries), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, and others).
  • Industry Participants: Abbott Laboratories, Adaptive Biotechnologies, Agilent Technologies, BGI Genomics, Biodesix, Bio-Rad Laboratories, F. Hoffmann-La Roche, Fulgent Genetics, Guardant Health, Laboratory Corporation of America Holdings, Illumina, Myriad Genetics, Natera, OPKO Health, PerkinElmer, Qiagen, Revvity, SOPHiA GENETICS, Stilla Technologies, Thermo Fisher Scientific.

Key Takeaways for Senior Decision-Makers

  • Advances in cfDNA testing are addressing clinical gaps in sensitivity, speed, and early disease intervention across high-impact areas such as oncology and prenatal care.
  • Integration of next-generation sequencing, automated workflows, and powerful data analytics supports earlier diagnostics and personalized therapy recommendations, underpinning greater value for clinicians and payers.
  • Industry collaboration—spanning clinical labs, academic partners, and technology vendors—promotes standardization and routes for reimbursement, facilitating broader clinical adoption.
  • Growth is shaped by region-specific regulatory requirements and diverse reimbursement models, compelling organizations to localize strategies to ensure access and compliance.
  • Emerging technology platforms, including single-molecule and epigenetic assays, are set to lead innovation, enabling further differentiation and competitive advantage in the market.

Assessing Tariff Impact on cfDNA Testing Accessibility

Recent US tariff implementations are reshaping the cost structure for cfDNA testing, with import duties on reagents and instruments prompting strategic shifts. Companies are prioritizing domestic sourcing, consolidating suppliers, and optimizing logistics to manage heightened procurement costs. Laboratories must adapt, aligning utilization protocols and clinical justification for price adjustments. Efforts to reinforce clinical utility with robust data are increasingly vital for sustaining reimbursement and coverage.

Methodology & Data Sources

This report relies on a multi-tiered research process, combining thorough reviews of peer-reviewed literature, regulatory publications, company reports, and subject matter expert interviews. Quantitative insights were cross-validated, and geographic segmentation confirmed through regional health authority data and feedback from industry stakeholders.

Why This Report Matters: Actionable Insights for Leadership

  • Empowers executives with nuanced market intelligence spanning technology trends, regulatory changes, and competitive shifts in cell-free DNA testing.
  • Guides strategic planning with granular segmentation analysis and regional perspectives, supporting informed investment and market entry decisions.
  • Supports operational efficiency by highlighting supply chain impacts and emerging reimbursement challenges essential for risk mitigation.

Conclusion

Cell-free DNA testing is poised for sustained evolution as innovation, market adaptation, and regulatory engagement intensify. Organizations leveraging data-driven positioning and stakeholder alignment will be best placed to harness emerging opportunities and drive future value in this sector.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of advanced bioinformatics pipelines to improve cfDNA variant detection sensitivity and specificity
5.2. Expansion of noninvasive prenatal testing panels to include microdeletion and monogenic disorder screening
5.3. Growing adoption of liquid biopsy assays for early cancer detection and monitoring therapeutic response
5.4. Strategic collaborations between diagnostic laboratories and pharmaceutical companies to co-develop cfDNA companion diagnostics
5.5. Leveraging machine learning algorithms to interpret fragmentomics patterns for enhanced disease classification
5.6. Rising demand for multiomic testing platforms combining cfDNA methylation and copy number analysis in oncology
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell-Free DNA Testing Market, by Offerings
8.1. Introduction
8.2. Infectious Diseases Testing
8.3. Oncology & Cancer Management
8.3.1. Early Detection and Screening
8.3.2. Minimal Residual Disease (MRD) Assessment
8.4. Prenatal Screening
8.4.1. Non-Invasive Prenatal Testing
8.4.2. Preimplantation Genetic Testing
8.5. Transplantation Testing
9. Cell-Free DNA Testing Market, by Technology Platform
9.1. Introduction
9.2. Mass Spectrometry
9.3. Microfluidics
9.4. Nucleic Acid Technology
9.5. Polymerase chain reaction (PCR)
9.6. Single-molecule Methylation
10. Cell-Free DNA Testing Market, by End-User
10.1. Introduction
10.2. Diagnostic Laboratories & Testing Centers
10.3. Hospitals & Clinics
11. Americas Cell-Free DNA Testing Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Cell-Free DNA Testing Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Cell-Free DNA Testing Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Abbott Laboratories
14.3.2. Adaptive Biotechnologies Corporation
14.3.3. Agilent Technologies, Inc.
14.3.4. BGI Genomics Co., Ltd.
14.3.5. Biodesix, Inc.
14.3.6. Bio-Rad Laboratories, Inc.
14.3.7. F. Hoffmann-La Roche
14.3.8. Fulgent Genetics, Inc.
14.3.9. Guardant Health, Inc.
14.3.10. Laboratory Corporation of America Holdings
14.3.11. llumina, Inc.
14.3.12. Myriad Genetics, Inc.
14.3.13. Natera, Inc.
14.3.14. OPKO Health, Inc.
14.3.15. PerkinElmer, Inc.
14.3.16. Qiagen N.V.
14.3.17. Revvity, Inc
14.3.18. SOPHiA GENETICS AG
14.3.19. Stilla Technologies
14.3.20. Thermo Fisher Scientific, Inc.
15. Research AI16. Research Statistics17. Research Contacts18. Research Articles19. Appendix
List of Figures
FIGURE 1. CELL-FREE DNA TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. CELL-FREE DNA TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. CELL-FREE DNA TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. CELL-FREE DNA TESTING MARKET: RESEARCHAI
FIGURE 22. CELL-FREE DNA TESTING MARKET: RESEARCHSTATISTICS
FIGURE 23. CELL-FREE DNA TESTING MARKET: RESEARCHCONTACTS
FIGURE 24. CELL-FREE DNA TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CELL-FREE DNA TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY INFECTIOUS DISEASES TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY INFECTIOUS DISEASES TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY EARLY DETECTION AND SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY EARLY DETECTION AND SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY MINIMAL RESIDUAL DISEASE (MRD) ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY MINIMAL RESIDUAL DISEASE (MRD) ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY NON-INVASIVE PRENATAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY NON-INVASIVE PRENATAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY TRANSPLANTATION TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY TRANSPLANTATION TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY NUCLEIC ACID TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY NUCLEIC ACID TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY SINGLE-MOLECULE METHYLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY SINGLE-MOLECULE METHYLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES & TESTING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES & TESTING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CELL-FREE DNA TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES CELL-FREE DNA TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 73. CANADA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 74. CANADA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 75. CANADA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 76. CANADA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 77. CANADA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 78. CANADA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 79. CANADA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 80. CANADA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 81. CANADA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 82. CANADA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 83. MEXICO CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 84. MEXICO CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 85. MEXICO CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 86. MEXICO CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 87. MEXICO CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 88. MEXICO CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 89. MEXICO CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 90. MEXICO CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 91. MEXICO CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 92. MEXICO CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 135. GERMANY CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 136. GERMANY CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 137. GERMANY CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 138. GERMANY CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 139. GERMANY CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 140. GERMANY CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 141. GERMANY CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 142. GERMANY CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 143. GERMANY CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 144. GERMANY CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 145. FRANCE CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 146. FRANCE CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 147. FRANCE CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 148. FRANCE CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 149. FRANCE CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 150. FRANCE CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 151. FRANCE CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 152. FRANCE CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 153. FRANCE CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 154. FRANCE CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 165. ITALY CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 166. ITALY CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 167. ITALY CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 168. ITALY CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 169. ITALY CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 170. ITALY CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 171. ITALY CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 172. ITALY CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 173. ITALY CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 174. ITALY CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 175. SPAIN CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 176. SPAIN CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 177. SPAIN CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 178. SPAIN CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 179. SPAIN CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 180. SPAIN CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 181. SPAIN CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 182. SPAIN CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 183. SPAIN CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 184. SPAIN CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 215. DENMARK CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 216. DENMARK CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 217. DENMARK CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 218. DENMARK CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 219. DENMARK CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 220. DENMARK CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 221. DENMARK CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 222. DENMARK CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 223. DENMARK CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 224. DENMARK CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 233. NETHERLANDS CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 234. NETHERLANDS CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 235. QATAR CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 236. QATAR CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 237. QATAR CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 238. QATAR CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 239. QATAR CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 240. QATAR CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 241. QATAR CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 242. QATAR CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 243. QATAR CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 244. QATAR CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 245. FINLAND CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 246. FINLAND CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 247. FINLAND CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 248. FINLAND CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 249. FINLAND CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 250. FINLAND CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 251. FINLAND CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 252. FINLAND CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 253. FINLAND CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 254. FINLAND CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 273. NIGERIA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 274. NIGERIA CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 275. EGYPT CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 276. EGYPT CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 277. EGYPT CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 278. EGYPT CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 279. EGYPT CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 280. EGYPT CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 281. EGYPT CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 282. EGYPT CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 283. EGYPT CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 284. EGYPT CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 285. TURKEY CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 286. TURKEY CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 287. TURKEY CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 288. TURKEY CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 289. TURKEY CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 290. TURKEY CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 291. TURKEY CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 292. TURKEY CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 293. TURKEY CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 294. TURKEY CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 303. ISRAEL CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 304. ISRAEL CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 305. NORWAY CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 306. NORWAY CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 307. NORWAY CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 308. NORWAY CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 309. NORWAY CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 310. NORWAY CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 311. NORWAY CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 312. NORWAY CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 313. NORWAY CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 314. NORWAY CELL-FREE DNA TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 315. POLAND CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 316. POLAND CELL-FREE DNA TESTING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 317. POLAND CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 318. POLAND CELL-FREE DNA TESTING MARKET SIZE, BY ONCOLOGY & CANCER MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 319. POLAND CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2024 (USD MILLION)
TABLE 320. POLAND CELL-FREE DNA TESTING MARKET SIZE, BY PRENATAL SCREENING, 2025-2030 (USD MILLION)
TABLE 321. POLAND CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 322. POLAND CELL-FREE DNA TESTING MARKET SIZE, BY TECHNOLOGY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cell-Free DNA Testing market report include:
  • Abbott Laboratories
  • Adaptive Biotechnologies Corporation
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Biodesix, Inc.
  • Bio‐Rad Laboratories, Inc.
  • F. Hoffmann‐La Roche
  • Fulgent Genetics, Inc.
  • Guardant Health, Inc.
  • Laboratory Corporation of America Holdings
  • llumina, Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • OPKO Health, Inc.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Revvity, Inc
  • SOPHiA GENETICS AG
  • Stilla Technologies
  • Thermo Fisher Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.19 billion
Forecasted Market Value ( USD ) by 2030 $ 10.36 billion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Cell-free DNA Mutation Diagnostics Market - Global Forecast 2025-2030 - Product Image

Cell-free DNA Mutation Diagnostics Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Cell-Free DNA Collection Tube Market - Global Forecast 2025-2030 - Product Image

Cell-Free DNA Collection Tube Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Cell Free DNA (cfDNA) Testing Market Report 2025 - Product Image

Cell Free DNA (cfDNA) Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cell Free Fetal DNA Testing Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Cell Free Fetal DNA Testing Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Cell-free Fetal DNA Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company) - Product Image

Cell-free Fetal DNA Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company)

  • Report
  • 270 Pages
  • Global
From

About the Market

The Cell Free DNA (cfDNA) market is a subset of the genomics industry that focuses on the analysis of circulating DNA fragments in the bloodstream. It is used to detect genetic abnormalities, such as chromosomal aneuploidy, and to monitor cancer progression. cfDNA testing is also used to detect fetal genetic abnormalities during pregnancy. The cfDNA market is expected to grow rapidly in the coming years, driven by increasing demand for non-invasive prenatal testing and the development of new technologies. The market is also expected to benefit from the increasing availability of cfDNA testing kits and the growing awareness of its potential applications. Notable companies in the cfDNA market include Illumina, Thermo Fisher Scientific, Qiagen, Natera, and Guardant Health. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.